drugset / Trial / NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of EpCAM-specific CAR T Cells infusion for EpCAM positive Cancer.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T cell immunotherapy | Cell therapy | 1e+06 cells/kg | Other |
| Subject | CAR-T cell immunotherapy | Cell therapy | 1e+07 cells/kg | Other |